Rivaroxaban targets procoagulant fibroblasts in the tumour microenvironment to reduce breast cancer cell migration and stem cell activity. Issue 1 (January 2022) - Blower, Emma; Castle, John; Santiago-Gomez, Angelica; Clarke, Robert; Kirwan, Cliona